Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1164 | 1021 | 1389 | 1350 | 1945 | 2657 |
Fund Return | 16.41% | 2.05% | 38.87% | 10.53% | 14.23% | 10.27% |
Place in category | 26 | 104 | 29 | 15 | 16 | 16 |
% in Category | 8 | 28 | 7 | 4 | 6 | 6 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 35.92B | 11.29 | 5.66 | 10.62 | ||
T. Rowe Price Blue Chip Growth | 32.75B | 28.40 | 5.04 | 14.38 | ||
T. Rowe Price Capital AppreciationI | 29.51B | 11.42 | 5.79 | - | ||
T. Rowe Price Blue Chip Growth I | 30.06B | 28.53 | 5.18 | - | ||
T. Rowe Price Instl Large Cap Growt | 22.88B | 24.63 | 5.87 | 15.66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Low-Priced Stock | 23.4B | 8.24 | 6.34 | 9.00 | ||
JHancock Disciplined Value Mid Cap | 15.87B | 10.71 | 7.35 | 9.70 | ||
Vanguard Mid-Cap Value Index Admira | 13.08B | 16.27 | 6.85 | 9.07 | ||
Victory Sycamore Established Value6 | 11.15B | 11.67 | 7.50 | 11.36 | ||
MFS Mid Cap Value R6 | 10.24B | 16.04 | 7.78 | 9.75 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Corning | US2193501051 | 3.06 | 48.00 | -0.54% | |
Select Medical | US81619Q1058 | 2.06 | 21.34 | +2.40% | |
Kenvue | US49177J1025 | 2.06 | 24.12 | -0.50% | |
Zimmer Biomet | US98956P1021 | 1.80 | 110.64 | -0.29% | |
Stanley Black Decker | US8545021011 | 1.72 | 89.54 | -3.22% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review